A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody

American Journal of Transplantation

Volumn 6, Issue 2, 2006, Pages 346-351

  Stegall, M D ^a   Gloor, J ^a   Winters, J L ^a   Moore, S B ^a   DeGoey, S ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Alloantibodies; Graft rejection; Humoral rejection; Immunoglobulin; Immunosuppressive agents; Intravenous; Kidney transplantation

Indexed keywords

ALLOANTIBODY; CD20 ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DESENSITIZATION; DRUG EFFICACY; FEMALE; GRAFT RECIPIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; TIME SERIES ANALYSIS;

ADULT; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MINNESOTA; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33644885700     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01178.x     Document Type: Article

References (14)

1. Montgomery RA Zachary AA Racusen LC Leffell MS King KE Burdick J et al Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 2000 70 887
2. Gloor JM DeGoey SR Pineda AA Moore SB Prieto M Nyberg SL et al Overcoming a positive crossmatch in living donor kidney transplantation Am J Transplant 2003 3 1017
3. Schweitzer EJ Wilson JS Fernandez-Vina M Fox M Gutierrez M Willand A et al A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants Transplantation 2000 70 1531
4. Jordan SC Vo A Bunnapradist S Toyoda M Peng A Puliyanda D et al Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 2003 76 631
5. Glotz D Antoine C Julia P Suberbielle-Boissel C Boudjeltia S Fraoui R et al Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulin Am J Transplant 2002 2 758
6. Tyan D Li V Czer L Trento A Jordan S Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ Transplantation 1994 57 553
7. Bearden CM Agarwal A Book BK et al Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab Human Immunol 2004 65 803 809
8. Gloor JM DeGoey S Ploeger N Gebel H Bray R Moore SB et al Persistence of low levels of alloantibody after desensitization in crossmatch positive living donor kidney transplantation Transplantation 2003 78 221
9. Winters JL Gloor JM Pineda AA Stegall MD Moore SB Plasma exchange conditioning for ABO-incompatible kidney transplantation J Clin Apheresis 2004 19 1
10. Racusen LC Colvin RB Solez K Mihatsch MJ Halloran PF Campbell PM et al Antibody-mediated rejection criteria- an addition to the Banff '97 classification of renal allograft rejection Am JTransplant 2003 3 708
11. Zachary AA Montgomery RA Ratner LE Samaniego-Picota M Haas M Kopchaliiska D et al Specific and durable elimination of antibody to donor HLA antigens in renal transplant patients Transplantation 2003 76 1519
12. Salama AD Delikouras A Pusey CD Cook HT Bhangal G Lechler RI et al Transplant accomodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody Am J Transplant 2001 1 260
13. Jordan SC Tyan D Stablein DM McIntosh M Vo A Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial Am J Transplant 2003 3 Suppl. 5 551
14. Vieira CA Agarwal A Book BK et al Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: safety, pharmacodynamics, and pharmacokinetics Transplantation 2004 77 542